9-(2-methylphenyl)-4-[3-(9-phenyl-7,8-dihydrocarbazol-1-yl)cyclohexa-1,5-dien-1-yl]carbazole
C43H34N2 — CID 146185724
Data last refreshed: (MolForge compound catalog, from PubChem)
About 9-(2-methylphenyl)-4-[3-(9-phenyl-7,8-dihydrocarbazol-1-yl)cyclohexa-1,5-dien-1-yl]carbazole
9-(2-methylphenyl)-4-[3-(9-phenyl-7,8-dihydrocarbazol-1-yl)cyclohexa-1,5-dien-1-yl]carbazole (PubChem CID 146185724) has the molecular formula C43H34N2 and a molecular weight of 578.76 g/mol. Its IUPAC name is 9-(2-methylphenyl)-4-[3-(9-phenyl-7,8-dihydrocarbazol-1-yl)cyclohexa-1,5-dien-1-yl]carbazole.
Molecular Properties
| Compound Name | 9-(2-methylphenyl)-4-[3-(9-phenyl-7,8-dihydrocarbazol-1-yl)cyclohexa-1,5-dien-1-yl]carbazole |
|---|---|
| PubChem CID | 146185724 |
| Molecular Formula | C43H34N2 |
| Molecular Weight | 578.76 g/mol |
| Exact Mass | 578.27 |
| IUPAC Name | 9-(2-methylphenyl)-4-[3-(9-phenyl-7,8-dihydrocarbazol-1-yl)cyclohexa-1,5-dien-1-yl]carbazole |
| SMILES | Cc1ccccc1-n1c2ccccc2c2c(C3=CC(c4cccc5c6c(n(-c7ccccc7)c45)CCC=C6)CC=C3)cccc21 |
| InChI | InChI=1S/C43H34N2/c1-29-14-5-8-24-38(29)45-40-26-10-7-20-37(40)42-33(21-13-27-41(42)45)30-15-11-16-31(28-30)34-22-12-23-36-35-19-6-9-25-39(35)44(43(34)36)32-17-3-2-4-18-32/h2-8,10-15,17-24,26-28,31H,9,16,25H2,1H3 |
| InChIKey | POZUFMOBMUJTCT-UHFFFAOYSA-N |
| XLogP | 11.12 |
| TPSA | 9.86 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 45 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 578.76 |
| LogP ≤ 5 | 11.12 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 2 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146185724 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.